JPS5149971Y2
(en)
*
|
1971-02-17 |
1976-12-02 |
|
|
CH543763A
(en)
*
|
1971-05-05 |
1973-04-13 |
Ebauches Sa |
Calendar timepiece
|
CH584926B5
(en)
*
|
1971-10-06 |
1977-02-15 |
Suisse Horlogerie |
|
CH577197B5
(en)
*
|
1971-10-29 |
1976-06-30 |
Ebauches Sa |
|
US3969888A
(en)
*
|
1972-12-11 |
1976-07-20 |
Cyril Veuilleumier |
Driving mechanism for day-date calendar device
|
DE2824917A1
(en)
|
1977-07-13 |
1979-02-01 |
Corning Glass Works |
BIOLOGICALLY ACTIVE CONJUGATES
|
WO1982000058A1
(en)
*
|
1980-06-20 |
1982-01-07 |
Porter P |
Processes and apparatus for carrying out specific binding assays
|
US4443112A
(en)
*
|
1982-09-29 |
1984-04-17 |
Timex Corporation |
Planetary gear for date mechanism in a wristwatch
|
JPS62231168A
(en)
|
1986-03-21 |
1987-10-09 |
ハイブリテツク・インコ−ポレイテツド |
Improvement method for forming internal standard for analyzing analite-receptor
|
US6562333B1
(en)
|
1993-06-14 |
2003-05-13 |
Schering Corporation |
Purified mammalian CTLA-8 antigens and related reagents
|
US5869451A
(en)
|
1995-06-07 |
1999-02-09 |
Glaxo Group Limited |
Peptides and compounds that bind to a receptor
|
ZA964814B
(en)
|
1995-06-07 |
1998-02-09 |
Glaxo Group Ltd |
Peptides and compounds that bind to a receptor.
|
AU4055697A
(en)
|
1996-08-16 |
1998-03-06 |
Schering Corporation |
Mammalian cell surface antigens; related reagents
|
ES2305009T5
(en)
|
1996-12-13 |
2012-11-15 |
Merck Sharp & Dohme Corp. |
Surface antigens of mammalian cells; related reagents
|
ATE458053T1
(en)
|
1997-05-07 |
2010-03-15 |
Schering Corp |
HUMAN TOLL-LIKE RECEPTOR PROTEINS, ASSOCIATED REAGENTS AND METHODS
|
ZA986051B
(en)
|
1997-07-09 |
1999-01-18 |
Schering Corp |
Isolated mammalian membrane protein genes related reagents
|
PE20000183A1
(en)
|
1997-07-25 |
2000-03-11 |
Schering Corp |
MAMMAL CYTOKINES AND RELATED REAGENTS
|
ATE341626T1
(en)
|
1997-08-01 |
2006-10-15 |
Schering Corp |
MEMBRANE PROTEINS FROM MAMMAL CELLS; RELATED REAGENTS
|
EP1967203A1
(en)
|
1998-07-15 |
2008-09-10 |
The Brigham and Women's Hospital |
Polysaccharide vaccine for staphylococcal infections
|
EP1115867A1
(en)
|
1998-09-21 |
2001-07-18 |
Schering Corporation |
Human interleukin-b50. therapeutic uses
|
EP0997476A3
(en)
|
1998-09-25 |
2000-07-19 |
Schering-Plough |
Antibodies to a mammalian Langerhans cell antigen and their uses
|
AU770807B2
(en)
|
1999-01-11 |
2004-03-04 |
Merck Sharp & Dohme Corp. |
Interleukin-17 related mammalian cytokines. polynucleotides encoding them. uses
|
HUP0203805A3
(en)
|
1999-05-13 |
2012-09-28 |
Medical Res Council |
Ox2 receptor homologs
|
DE60041697D1
(en)
|
1999-06-01 |
2009-04-16 |
Schering Corp |
MAMMALIAN RECEPTOR PROTEINS; SIMILAR REAGENTS AND METHODS
|
US6599727B1
(en)
|
1999-06-16 |
2003-07-29 |
Icos Corporation |
Human poly (ADP-ribose) polymerase 2 materials and methods
|
ATE440953T1
(en)
|
1999-07-30 |
2009-09-15 |
Schering Corp |
MAMMAL CYTOKINE AND ASSOCIATED REAGENTS
|
US7668658B2
(en)
*
|
1999-10-13 |
2010-02-23 |
Sequenom, Inc. |
Methods for generating databases and databases for identifying polymorphic genetic markers
|
US7109299B1
(en)
|
1999-12-16 |
2006-09-19 |
Affymax, Inc. |
Peptides and compounds that bind to the IL-5 receptor
|
US7422743B2
(en)
|
2000-05-10 |
2008-09-09 |
Schering Corporation |
Mammalian receptor protein DCRS5;methods of treatment
|
WO2001085790A2
(en)
|
2000-05-10 |
2001-11-15 |
Schering Corporation |
Mammalian cytokine receptor subunit proteins, related reagents and methods
|
CN1222539C
(en)
|
2000-05-25 |
2005-10-12 |
先灵公司 |
Human receptor proteins, related reagents and methods
|
EP2298789B1
(en)
|
2000-09-08 |
2012-03-14 |
Schering Corporation |
Mammalian genes; related reagents and methods
|
US6890734B2
(en)
|
2000-11-10 |
2005-05-10 |
Schering Corporation |
Nucleic acids encoding a cytokine receptor complex
|
US7087726B2
(en)
|
2001-02-22 |
2006-08-08 |
Genentech, Inc. |
Anti-interferon-α antibodies
|
AU2002305052A1
(en)
|
2001-03-13 |
2002-09-24 |
Corvas International, Inc. |
Nucleic acid molecules encoding a transmembrane serine protease 7, the encoded polypeptides and methods based thereon
|
KR20040011480A
(en)
|
2001-03-22 |
2004-02-05 |
덴드레온 샌 디에고 엘엘씨 |
Nucleic acid molecules encoding serine protease CVSP14, the encoded polypeptides and methods based thereon
|
JP2005506047A
(en)
|
2001-03-27 |
2005-03-03 |
デンドレオン・サンディエゴ・リミテッド・ライアビリティ・カンパニー |
Nucleic acid molecule encoding transmembrane serine protease 9, encoded polypeptide and methods based thereon
|
WO2002092841A2
(en)
|
2001-05-14 |
2002-11-21 |
Dendreon San Diego Llc |
Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
|
EP1439188A4
(en)
|
2001-09-25 |
2006-04-26 |
Japan Government |
Search for cancer marker by novel screening method
|
EP2072059A1
(en)
|
2001-10-12 |
2009-06-24 |
Schering Corporation |
Use of bispecific antibodies to regulate immune responses
|
US20030134794A1
(en)
*
|
2001-11-20 |
2003-07-17 |
Madison Edwin L. |
Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
|
AU2003228809A1
(en)
*
|
2002-05-03 |
2003-11-17 |
Sequenom, Inc. |
Kinase anchor protein muteins, peptides thereof, and related methods
|
US20040001801A1
(en)
*
|
2002-05-23 |
2004-01-01 |
Corvas International, Inc. |
Conjugates activated by cell surface proteases and therapeutic uses thereof
|
AU2004205684A1
(en)
*
|
2003-01-23 |
2004-08-05 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
WO2005067692A2
(en)
*
|
2004-01-13 |
2005-07-28 |
U.S. Genomics, Inc. |
Detection and quantification of analytes in solution using polymers
|
MXPA06011824A
(en)
*
|
2004-04-16 |
2006-12-15 |
Genentech Inc |
Assay for antibodies.
|
JP5064212B2
(en)
|
2004-05-05 |
2012-10-31 |
ヴァロリザーシヨン−ルシェルシュ,ソシエテ・アン・コマンディット |
INTERLEUKIN-1 RECEPTOR ANTAGONIST, COMPOSITION AND METHOD OF TREATMENT
|
US20060014680A1
(en)
*
|
2004-07-13 |
2006-01-19 |
Caiding Xu |
Peptides and compounds that bind to the IL-5 receptor
|
MX2007001589A
(en)
*
|
2004-08-09 |
2007-08-02 |
Alios Biopharma Inc |
Synthetic hyperglycosylated, protease-resistant polypeptide variants, oral formulations and methods of using the same.
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
AU2006264567A1
(en)
|
2005-05-05 |
2007-01-11 |
Valorisation Hsj, Societe En Commandite |
Cytokine receptor modulators and uses thereof
|
WO2006122401A1
(en)
*
|
2005-05-16 |
2006-11-23 |
Institut De Recherches Cliniques De Montreal/I.R.C.M. |
Negative regulation of nk cell functions by eat-2, a sap-related adaptor expressed in innate immune cells
|
US20100035247A1
(en)
*
|
2005-11-04 |
2010-02-11 |
U.S. Genomics, Inc. |
Heterogeneous Assay of Analytes in Solution Using Polymers
|
BRPI0706840A2
(en)
|
2006-01-05 |
2011-04-05 |
Genentech Inc |
polynucleotide isolated anti-ephb4 antibodies, vector, host cell, method for producing an anti ephb4 antibody, method for producing an anti ephb4 immunoconjugate, method for detecting ephb4, method for diagnosing a composition disorder, method for inhibiting angiogenesis, method for treating a cancer, tumor and / or cell proliferation disorder and use of an antibody
|
AU2007210068A1
(en)
|
2006-01-26 |
2007-08-09 |
The Board Of Regents, The University Of Texas System |
Process and apparatus for imaging
|
AR059851A1
(en)
|
2006-03-16 |
2008-04-30 |
Genentech Inc |
ANTIBODIES OF EGFL7 AND METHODS OF USE
|
EP2069778A2
(en)
*
|
2006-08-03 |
2009-06-17 |
Numira Biosciences, Inc. |
Methods and compositions for identifying biomarkers
|
KR101551984B1
(en)
|
2006-10-04 |
2015-09-09 |
제넨테크, 인크. |
ELISA for VEGF
|
US20080171344A1
(en)
*
|
2006-12-22 |
2008-07-17 |
Kapsner Kenneth P |
Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
|
PE20090321A1
(en)
|
2007-06-04 |
2009-04-20 |
Genentech Inc |
ANTI-NOTCH1 NRR ANTIBODIES, METHOD OF PREPARATION AND PHARMACEUTICAL COMPOSITION
|
WO2009036209A2
(en)
|
2007-09-14 |
2009-03-19 |
Amgen Inc. |
Homogeneous antibody populations
|
TWI580694B
(en)
|
2007-11-30 |
2017-05-01 |
建南德克公司 |
Anti-vegf antibodies
|
WO2010017248A2
(en)
|
2008-08-04 |
2010-02-11 |
University Of Miami |
Sting (stimulator of interferon genes), a regulator of innate immune responses
|
NZ599600A
(en)
*
|
2009-10-26 |
2015-04-24 |
Genentech Inc |
Assays for detecting antibodies specific to therapeutic anti-ige antibodies and their use in anaphylaxis
|
BR112012010153B1
(en)
|
2009-11-05 |
2022-05-03 |
Genentech, Inc |
Method of producing an antibody
|
US8486397B2
(en)
|
2009-12-11 |
2013-07-16 |
Genentech, Inc. |
Anti-VEGF-C antibodies and methods using same
|
AU2010336485B2
(en)
|
2009-12-23 |
2015-03-26 |
Genentech, Inc. |
Anti-Bv8 antibodies and uses thereof
|
US9216189B2
(en)
|
2010-01-25 |
2015-12-22 |
Icahn School Of Medicine At Mount Sinai |
Antibodies which bind type I cannabinoid receptor/angiotensis II receptor heteromers
|
WO2012030738A2
(en)
|
2010-08-30 |
2012-03-08 |
Beckman Coulter, Inc. |
Complex phosphoprotein activation profiles
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
WO2012149320A1
(en)
|
2011-04-29 |
2012-11-01 |
Bristol-Myers Squibb Company |
Ip-10 antibody dosage escalation regimens
|
ES2641325T3
(en)
|
2012-01-26 |
2017-11-08 |
Christopher J. Soares |
Peptide antagonists of the CGRP calcitonin family of peptide hormones and their use
|
US9708411B2
(en)
|
2012-02-16 |
2017-07-18 |
The Penn Research Foundation |
Modulators of acyl-CoA lysocardiolipin acyltransferase 1 (ALCAT1) and uses thereof
|
WO2013142796A2
(en)
|
2012-03-23 |
2013-09-26 |
Bristol-Myers Squibb Company |
Methods of treatments using ctla4 antibodies
|
CN104334583A
(en)
|
2012-03-28 |
2015-02-04 |
弗·哈夫曼-拉罗切有限公司 |
Anti-HCMV idiotypic antibodies and uses thereof
|
RU2014152261A
(en)
|
2012-05-30 |
2016-07-20 |
Дзе Брихэм Энд Уимен'З Хоспитал, Инк. |
COMPOSITIONS OF POLYSACCHARIDES AND METHODS OF APPLICATION
|
CN104755498B
(en)
|
2012-08-31 |
2019-06-18 |
伊缪诺金公司 |
For detecting the diagnostic assay and kit of folacin receptor 1
|
US9733263B2
(en)
|
2012-11-07 |
2017-08-15 |
Lotus Tissue Repair Inc. |
Collagen IV binding assay for the detection of collagen VII
|
CN113150145A
(en)
|
2013-08-30 |
2021-07-23 |
伊缪诺金公司 |
Antibodies and assays for detecting folate receptor 1
|
CA3174012A1
(en)
|
2013-09-13 |
2015-03-19 |
Genentech, Inc. |
Compositions and methods for detecting and quantifying host cell protein in cell lines and recombinant polypeptide products
|
KR102373930B1
(en)
|
2013-09-13 |
2022-03-11 |
제넨테크, 인크. |
Methods and compositions comprising purified recombinant polypeptides
|
WO2015057402A1
(en)
|
2013-10-18 |
2015-04-23 |
University Health Network |
Proteasome inhibition assay and methods of use
|
ES2897765T3
(en)
|
2014-03-14 |
2022-03-02 |
Hoffmann La Roche |
Methods and compositions for the secretion of heterologous polypeptides
|
WO2016069912A1
(en)
|
2014-10-29 |
2016-05-06 |
Massachusetts Eye And Ear Infirmary |
Efficient delivery of therapeutic molecules in vitro and in vivo
|
EP3212773B1
(en)
|
2014-10-29 |
2021-09-15 |
Massachusetts Eye and Ear Infirmary |
Efficient delivery of therapeutic molecules to cells of the inner ear
|
KR20170122216A
(en)
|
2015-03-06 |
2017-11-03 |
제넨테크, 인크. |
Ultra-pure water DSBA and DSBC, and methods for manufacturing and using them
|
JP6492928B2
(en)
*
|
2015-04-22 |
2019-04-03 |
セイコーエプソン株式会社 |
Timepiece and timepiece manufacturing method
|
EP3932953A1
(en)
|
2015-08-28 |
2022-01-05 |
F. Hoffmann-La Roche AG |
Anti-hypusine antibodies and uses thereof
|
US10816549B2
(en)
|
2015-12-15 |
2020-10-27 |
Case Western Reserve University |
Epithelial cancer evaluation using beta defensin
|
US11353468B2
(en)
|
2016-04-14 |
2022-06-07 |
Lonza Ltd. |
Compositions and methods for the detection of host cell proteins
|
EP3316048B1
(en)
*
|
2016-10-28 |
2020-03-18 |
Rolex Sa |
Clockwork mechanism for displaying and correcting a plurality of information
|
WO2018136553A1
(en)
|
2017-01-18 |
2018-07-26 |
Genentech, Inc. |
Idiotypic antibodies against anti-pd-l1 antibodies and uses thereof
|
CH713604A1
(en)
|
2017-03-22 |
2018-09-28 |
Sa De La Manufacture Dhorlogerie Audemars Piguet & Cie |
Selection and actuation mechanism as well as a device for adjusting the functions of a timepiece.
|
KR102172820B1
(en)
*
|
2017-07-25 |
2020-11-03 |
불랑패인쏘시에떼아노님 |
Torque smoothing for a timepiece, particularly with a striking mechanism
|
EP3584643B1
(en)
*
|
2018-06-19 |
2020-11-11 |
Manufacture d'Horlogerie Audemars Piguet SA |
Instantaneous command device for date display of timepieces
|
EP3786725A1
(en)
*
|
2019-08-26 |
2021-03-03 |
Blancpain SA |
Disengagement of two gear trains
|
CN115461375A
(en)
|
2020-04-30 |
2022-12-09 |
基因泰克公司 |
KRAS-specific antibodies and uses thereof
|
US20230382978A1
(en)
|
2020-10-15 |
2023-11-30 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Antibody specific for sars-cov-2 receptor binding domain and therapeutic methods
|
WO2022087274A1
(en)
|
2020-10-21 |
2022-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibodies that neutralize type-i interferon (ifn) activity
|
CN117321076A
(en)
|
2021-02-19 |
2023-12-29 |
美国卫生及公众服务部代表 |
Single domain antibodies neutralizing SARS-CoV-2
|